CDA
Basic information
Region (hg38): 1:20589086-20618903
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 6 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 6 | 0 | 2 |
Variants in CDA
This is a list of pathogenic ClinVar variants found in the CDA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-20589245-G-C | not specified | Uncertain significance (Nov 17, 2023) | ||
1-20604956-G-A | Benign (Mar 29, 2018) | |||
1-20604983-T-C | Benign (Jul 10, 2018) | |||
1-20605032-A-C | not specified | Uncertain significance (Jul 25, 2023) | ||
1-20613861-A-G | not specified | Uncertain significance (Aug 12, 2021) | ||
1-20618478-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
1-20618486-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
1-20618495-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
1-20618510-C-T | not specified | Uncertain significance (May 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDA | protein_coding | protein_coding | ENST00000375071 | 4 | 29961 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00810 | 0.803 | 125725 | 0 | 5 | 125730 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.297 | 75 | 82.6 | 0.908 | 0.00000454 | 950 |
Missense in Polyphen | 26 | 29.355 | 0.88571 | 345 | ||
Synonymous | 0.872 | 28 | 34.5 | 0.811 | 0.00000214 | 279 |
Loss of Function | 1.02 | 4 | 6.90 | 0.580 | 3.00e-7 | 86 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000547 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000901 | 0.00000879 |
Middle Eastern | 0.0000547 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: This enzyme scavenges exogenous and endogenous cytidine and 2'-deoxycytidine for UMP synthesis.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Fluoropyrimidine Pathway, Pharmacokinetics;Gemcitabine Pathway, Pharmacodynamics;Pyrimidine Metabolism;Capecitabine Action Pathway;Capecitabine Metabolism Pathway;UMP Synthase Deiciency (Orotic Aciduria);MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy);Beta Ureidopropionase Deficiency;Dihydropyrimidinase Deficiency;Fluoropyrimidine Activity;pyrimidine ribonucleosides degradation;Pyrimidine metabolism;Neutrophil degranulation;pyrimidine deoxyribonucleosides degradation;Metabolism of nucleotides;Innate Immune System;Immune System;Metabolism;Pyrimidine salvage;Nucleotide salvage;Pyrimidine metabolism;pyrimidine ribonucleosides degradation;superpathway of pyrimidine deoxyribonucleoside salvage;Pyrimidine nucleotides nucleosides metabolism;pyrimidine ribonucleosides salvage I;pyrimidine deoxyribonucleosides salvage
(Consensus)
Recessive Scores
- pRec
- 0.553
Intolerance Scores
- loftool
- 0.229
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.75
Haploinsufficiency Scores
- pHI
- 0.191
- hipred
- N
- hipred_score
- 0.332
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.808
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cda
- Phenotype
Gene ontology
- Biological process
- cell surface receptor signaling pathway;pyrimidine-containing compound salvage;cytidine deamination;cytosine metabolic process;negative regulation of cell growth;pyrimidine nucleoside salvage;neutrophil degranulation;negative regulation of nucleotide metabolic process;protein homotetramerization
- Cellular component
- extracellular region;cytosol;secretory granule lumen;tertiary granule lumen;ficolin-1-rich granule lumen
- Molecular function
- nucleoside binding;cytidine deaminase activity;protein binding;zinc ion binding;protein homodimerization activity